Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes. Borderie G, Schnebelen M, Baynat L. N Engl J Med 2021;385:2105-2106.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Borderie G, Schnebelen M, Baynat L. Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes. N Engl J Med 2021;385:2105-2106.
PMID: 34818489